2015
DOI: 10.1002/14651858.cd009403.pub2
|View full text |Cite
|
Sign up to set email alerts
|

Vitamin B and its derivatives for diabetic kidney disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
17
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(17 citation statements)
references
References 107 publications
0
17
0
Order By: Relevance
“…The majority of patients with CKD can develop vitamin B6 deficiency from many causes [ 33 ]. Abnormal vitamin B6 level has been reported to be associated with diabetic kidney disease [ 34 ], kidney stones [ 35 ], and kidney cancer [ 36 ]. Skrypnyk et al found that treatment with pyridoxamine, a structural analog of vitamin B6, reduced short- and long-term injury, fibrosis, and renal functional recovery after ischemia-reperfusion AKI [ 37 ].…”
Section: Discussionmentioning
confidence: 99%
“…The majority of patients with CKD can develop vitamin B6 deficiency from many causes [ 33 ]. Abnormal vitamin B6 level has been reported to be associated with diabetic kidney disease [ 34 ], kidney stones [ 35 ], and kidney cancer [ 36 ]. Skrypnyk et al found that treatment with pyridoxamine, a structural analog of vitamin B6, reduced short- and long-term injury, fibrosis, and renal functional recovery after ischemia-reperfusion AKI [ 37 ].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, as data on medications and supplements consumption was self-reported, a reporting bias might exist, that is, individuals could potentially avoid disclosing their real intake. However, such a bias is expected to be insignificant, as the reporting bias for group B vitamin consumption, was shown to be generally low [41]. …”
Section: Discussionmentioning
confidence: 99%
“…Several studies have reported potential therapeutic applications for thiamine in treating diabetic complications (Raval et al, 2015;Kohda et al, 2008Kohda et al, , 2009Kohda et al, , 2010Kohda et al, , 2012aTanaka et al, 2010). In vitro studies have demonstrated that thiamine decreases apoptosis induced by high glucose conditioned extracellular matrix in human retinal pericytes, and a pilot study supported the use of highdose thiamine as a potential treatment for end-stage diabetic nephropathy (Rabbani et al, 2009;Beltramo et al, 2009).…”
Section: Introductionmentioning
confidence: 98%